| Product Name | MF | CAS | Details |
|---|
| Ethyl 2-O-benzoyl-4,6-O-benzylidene-β-D-galactopyranoside | C22H24O7 | 161765-88-4 | Details |
| R 7128 | C18H26FN3O6 | 940908-79-2 | Details |
| 1-Benzoylpyrrolidine | C11H13NO | 3389-54-6 | Details |
| 3-Aminopropyltris(trimethylsiloxy)silane | C12H35NO3Si4 | 25357-81-7 | Details |
| 4-Chloro-7-methoxyquinoline-6-carboxamide | C11H9ClN2O2 | 417721-36-9 | Details |
| 4-Fluoro-3-methoxybenzylamine hydrochloride | C8H11ClFNO | 869296-41-3 | Details |
| PSMC4 Blocking Peptide | Details |
| 5'-O-DMT-2'-O-(2-methoxyethyl)uridine 3'-CE phosphoramidite | C42H53N4O10P | 163759-97-5 | Details |
| 4-(Piperidin-1-yl)benzene-1,2-diamine | C11H17N3 | 155198-10-0 | Details |
| RAB39B antibody | Details |
| BD1 antibody | Details |
| Spiro[3.5]nonan-5-amine | C9H17N | 1554223-36-7 | Details |
| (E)-1-fluoro-4-(2-nitrovinyl)benzene | C8H6FNO2 | 5153-69-5 | Details |
| tert-Butyl N-{thieno[3,2-b]pyridin-2-yl}carbamate | C12H14N2O2S | 2287298-17-1 | Details |
| Bamaluzole | C14H12ClN3O | 87034-87-5 | Details |
| 5-(Morpholin-4-ylmethyl)pyridin-2-amine | C10H15N3O | 400775-78-2 | Details |
| 2-(5-Chloro-1,3-dimethyl-1H-pyrazol-4-yl)acetic acid | C7H9ClN2O2 | 1007515-41-4 | Details |
| N'-Hydroxy-2-methylbenzimidamide | C8H10N2O | 1056156-96-7 | Details |
| Boc-D-Lys-OH | C11H22N2O4 | 106719-44-2 | Details |
| 6,8-Difluoro-3,4-dihydro-2H-1,4-benzoxazine | C8H7F2NO | 939759-10-1 | Details |
| NAP1L2 antibody | Details |
| 1-(Dimethylsulfamoyl)pyrazole | C5H9N3O2S | 133228-21-4 | Details |
| AG 221 | C19H17F6N7O | 1446502-11-9 | Details |
| Ionomycin | C41H72O9 | 56092-81-0 | Details |
| Fmoc-homocyclohexyl-L-alanine | C25H29NO4 | 269078-73-1 | Details |
| Methyl 4,6-O-benzylidene-β-D-glucopyranoside | C14H18O6 | 14155-23-8 | Details |
| 1-(2-Methyl-1,3-oxazol-4-yl)ethan-1-one | C6H7NO2 | 81740-16-1 | Details |
| 4-Propyl-5-sulfanyl-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2(7),5-trien-3-one | C13H16N2OS2 | 126105-95-1 | Details |
| 2-(3-Cyclopropyl-1H-pyrazol-1-yl)benzonitrile | C13H11N3 | 1248441-89-5 | Details |
| RPL18 Blocking Peptide | Details |
| 2-(3-Aminopropyl)cyclohexan-1-ol | C9H19NO | 91425-85-3 | Details |
| Methyl 2,3,4-tri-O-acetyl-6-O-tert-butyldimethylsilyl-a-D-glucopyranoside | C19H34O9Si | 63734-11-2 | Details |
| Thiepan-4-ylmethanamine hydrochloride | 2172560-64-2 | Details |
| rpsS protein (His tag) | Details |
| Exopolysaccharide - from Flavobacterium | Details |
| 2-(Propan-2-yloxy)pyrimidin-5-amine | C7H11N3O | 1249668-06-1 | Details |
| 2-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2-methyl-4-phenylbutanoic acid | C26H25NO4 | 1693866-72-6 | Details |
| 1-(4-Aminophenyl)-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one | C11H9N5O | 1050884-19-9 | Details |
| 4-(4-Chloro-3-methyl-1H-pyrazol-1-yl)benzaldehyde | C11H9ClN2O | 1339554-40-3 | Details |
| 4-(tert-Butyldimethylsilyloxymethyl)pyridine | C12H21NOSi | 117423-41-3 | Details |
| 1-(2-Methanesulfonylphenyl)propan-2-ol | C10H14O3S | 1409557-45-4 | Details |
| 2-(3-Bromobenzenesulfonyl)acetic acid | C8H7BrO4S | 3937-93-7 | Details |
| 2,2,2-Trifluoro-N-(3-oxo-2,3-dihydro-1H-inden-1-yl)acetamide | C11H8F3NO2 | 117391-20-5 | Details |
| 2-Fluorobenzhydrazide | C7H7FN2O | 446-24-2 | Details |
| tert-Butyl 6-(aminomethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate | C11H20N2O2 | 1272425-00-9 | Details |
| trans 4-Dimethylaminocrotonic acid HCl | C6H12ClNO2 | 848133-35-7 | Details |
| Ac-CRQIKIWFQNRRMKWKK-NH2 | Details |
| (-)-Eburnamonine | C19H22N2O | 4880-88-0 | Details |
| (Z)-(5-Bromo-2-thienyl)ethanone oxime | C9H7FN2O | 915402-26-5 | Details |
| monoFITC RLN2 | Details |
| {Bicyclo[4.1.0]heptan-2-yl}methanamine | C8H15N | 1543311-07-4 | Details |
| 2-(4-Fluorophenyl)-7-methylimidazo[1,2-a]pyridin-3-amine | C14H12FN3 | 851879-21-5 | Details |
| Vitedoin A | C20H20O6 | 819861-40-0 | Details |
| 1-[(Cyclopentylcarbamoyl)methyl]-6-cyclopropyl-3-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid | C18H22N4O3 | 1018142-06-7 | Details |
| 6-Carboxy-X-rhodamine | C33H30N2O5 | 194785-18-7 | Details |
| Anti-SLIT2 antibody - 2mg/mL | Details |
| CYC1 Blocking Peptide | Details |
| 1,6-Anhydro-4-O-p-toluenesufonyl-b-D-glucopyranose | C13H16O7S | 23643-29-0 | Details |
| LUF7346 | C20H15BrN2O3 | 1821638-40-7 | Details |
| 1,2-Dipalmitoyl-3-octanoyl-rac-glycerol | C43H82O6 | 145134-89-0 | Details |
| 2-Bromo-6-chlorobenzene-1-sulfonamide | C6H5BrClNO2S | 1261551-83-0 | Details |
| Alpha-amino-4-octylbenzenebutanoic acid | C18H29NO2 | 596820-19-8 | Details |
| H-LSAPGSQR-OH | Details |
| BMS 986202 | C15H21KN6O6 | 675839-33-5 | Details |
| tert-Butyl N-[2-(propan-2-yloxy)pyridin-4-yl]carbamate | C13H20N2O3 | 1936610-26-2 | Details |
| Methyl 2,3,4-tri-O-acetyl-6-O-tert-butyldiphenylsilyl-a-D-glucopyranoside | C29H38O9Si | 790685-09-5 | Details |
| β-Ala-Lys(AMCA) | C21H28N4O6 | 180342-52-3 | Details |
| GADD45A antibody | Details |
| 4-Isobutylcinnamic acid | C13H16O2 | 66734-95-0 | Details |
| 3,4-Difluorostyrene | C8H6F2 | 405-03-8 | Details |
| 3-Bromo-1-fluoronaphthalene | C10H6BrF | 13772-59-3 | Details |
| Baimaside | 27459-71-8 | Details |
| tert-Butyl 2-(4-methyl-1,3-thiazol-2-yl)acetate | C10H15NO2S | 1211112-27-4 | Details |
| 5-(Chloromethyl)-2-cyclopropyl-1,3-thiazole | C7H8ClNS | 1468426-47-2 | Details |
| Methyl (2S,4R)-4-ethoxypyrrolidine-2-carboxylate hydrochloride | 2287249-69-6 | Details |
| 5-(Hydroxymethyl)-5-methylpiperidin-2-one | C7H13NO2 | 1909336-03-3 | Details |
| rac-(2R,3S)-1-[(tert-Butoxy)carbonyl]-3-hydroxypyrrolidine-2-carboxylic acid | C10H17NO5 | 186132-80-9 | Details |
| Angelol K | C20H24O7 | 169736-93-0 | Details |
| (R)-1-(2-Chloro-pyrimidin-4-yl)-pyrrolidin-3-ol | C8H10ClN3O | 1083089-94-4 | Details |
| LYN Blocking Peptide | Details |
| H-IPVIIER^-OH | Details |
| 2-(4-Bromobenzenesulfonyl)ethan-1-amine | C8H10BrNO2S | 771584-35-1 | Details |
| 2-Chloro-4-methoxypyridin-3-amine | C6H7ClN2O | 173435-34-2 | Details |
| 2-(4-Phenylcyclohexyl)ethan-1-amine hydrochloride | C14H22ClN | 1195262-94-2 | Details |
| Psiguadial D | C30H34O5 | 1402066-95-8 | Details |
| 2-boc-2-azabicyclo[2.2.2]octane-6-one | C12H19NO3 | 1311390-85-8 | Details |
| Ac-Met-AMC | C17H20N2O4S | 354152-20-8 | Details |
| [3-(Pyridin-2-yl)-1H-1,2,4-triazol-5-yl]methanamine hydrochloride | 1909317-03-8 | Details |
| H-2Kb Mouse Survivin MFFCFKEL | Details |
| N-Benzyl-4-(4-methoxynaphthalen-1-yl)-1,3-thiazol-2-amine hydrobromide | C21H19BrN2OS | 1052544-77-0 | Details |
| ethyl 4-hydroxy-3,5-dimethoxy-benzoate | C11H14O5 | 3943-80-4 | Details |
| Ethyl 2-(3-nitrophenyl)acetate | C10H11NO4 | 14318-64-0 | Details |
| Leucettine L41 | C17H13N3O3 | 1112978-84-3 | Details |
| (4-Chlorophenyl)(1-methyl-1H-imidazol-2-yl)methylamine | C11H12ClN3 | 871217-40-2 | Details |
| 3,4,5,6-Tetrahydro-2H-1λ?,2,5-benzothiadiazocine-1,1,4,6-tetrone | C9H8N2O4S | 2089257-76-9 | Details |
| CYP2A7 Blocking Peptide | Details |
| 2-(3,4-Dichlorophenyl)-4-fluorobenzoic acid | C13H7Cl2FO2 | 926239-53-4 | Details |
| LGALS3BP antibody | Details |
| 3-Chloro-2-hydroxyimipramine | C19H23ClN2O | 61523-75-9 | Details |
| (3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl acetate | C11H12F3NO3 | 112525-75-4 | Details |
| Product Total： Product Page： | ||||
| 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 | ||||